These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 32057846)
1. Biodistribution and pharmacokinetics of thiolated chitosan nanoparticles for oral delivery of insulin in vivo. Sudhakar S; Chandran SV; Selvamurugan N; Nazeer RA Int J Biol Macromol; 2020 May; 150():281-288. PubMed ID: 32057846 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study. Barbari GR; Dorkoosh F; Amini M; Bahari Javan N; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M Int J Nanomedicine; 2018; 13():5127-5138. PubMed ID: 30233176 [TBL] [Abstract][Full Text] [Related]
3. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Yin L; Ding J; He C; Cui L; Tang C; Yin C Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735 [TBL] [Abstract][Full Text] [Related]
4. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery. Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318 [TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan. Krauland AH; Leitner VM; Grabovac V; Bernkop-Schnürch A J Pharm Sci; 2006 Nov; 95(11):2463-72. PubMed ID: 16886206 [TBL] [Abstract][Full Text] [Related]
6. Thiolated Nanoparticles Overcome the Mucus Barrier and Epithelial Barrier for Oral Delivery of Insulin. Zhou S; Deng H; Zhang Y; Wu P; He B; Dai W; Zhang H; Zhang Q; Zhao R; Wang X Mol Pharm; 2020 Jan; 17(1):239-250. PubMed ID: 31800258 [TBL] [Abstract][Full Text] [Related]
7. Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin. Elsayed A; Al-Remawi M; Qinna N; Farouk A; Al-Sou'od KA; Badwan AA AAPS PharmSciTech; 2011 Sep; 12(3):958-64. PubMed ID: 21761276 [TBL] [Abstract][Full Text] [Related]
8. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Su FY; Lin KJ; Sonaje K; Wey SP; Yen TC; Ho YC; Panda N; Chuang EY; Maiti B; Sung HW Biomaterials; 2012 Mar; 33(9):2801-11. PubMed ID: 22243802 [TBL] [Abstract][Full Text] [Related]
9. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015 [TBL] [Abstract][Full Text] [Related]
10. Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment. Mumuni MA; Kenechukwu FC; Ofokansi KC; Attama AA; Díaz DD Carbohydr Polym; 2020 Feb; 229():115506. PubMed ID: 31826394 [TBL] [Abstract][Full Text] [Related]
11. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery. Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774 [TBL] [Abstract][Full Text] [Related]
12. Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles. Alsulays BB; Anwer MK; Soliman GA; Alshehri SM; Khafagy ES Int J Nanomedicine; 2019; 14():9127-9138. PubMed ID: 31819423 [TBL] [Abstract][Full Text] [Related]
13. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation. Fan B; Xing Y; Zheng Y; Sun C; Liang G Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290 [TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Makhlof A; Tozuka Y; Takeuchi H Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882 [TBL] [Abstract][Full Text] [Related]
16. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322 [TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin loaded nanoparticles of disulfide bridged thiolated chitosan-eudragit RS100 for controlled drug delivery. Iqbal O; Shah S; Abbas G; Rasul A; Hanif M; Ashfaq M; Afzal Z Int J Biol Macromol; 2021 Jul; 182():2087-2096. PubMed ID: 34087298 [TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery. Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048 [TBL] [Abstract][Full Text] [Related]
19. Chitosan coating of zein-carboxymethylated short-chain amylose nanocomposites improves oral bioavailability of insulin in vitro and in vivo. Ji N; Hong Y; Gu Z; Cheng L; Li Z; Li C J Control Release; 2019 Nov; 313():1-13. PubMed ID: 31622690 [TBL] [Abstract][Full Text] [Related]
20. Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model. Mukhopadhyay P; Sarkar K; Chakraborty M; Bhattacharya S; Mishra R; Kundu PP Mater Sci Eng C Mater Biol Appl; 2013 Jan; 33(1):376-82. PubMed ID: 25428084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]